TABLE 1.
Antibody | Description | Application | Source |
---|---|---|---|
TLR4 | Transmembrane receptor | WB, IHC | Santa cruz |
MyD88 | Myeloid differentiation protein | WB | Santa cruz |
p-NF-κB p65 | Activated transcription factor | WB | Santa cruz |
NF-κB p65 | Transcription factor | WB, IHC | Santa cruz |
p-IκBα | Activated inhibitory protein of NF-κB | WB | Cell signaling technology |
IκBα | Inhibitory protein of NF-κB | WB | Cell signaling technology |
p-IKKα/β | Activated IκB kinase | WB | Cell signaling technology |
IKKα | IκB kinase | WB | Cell signaling technology |
IKKβ | IκB kinase | WB | Cell signaling technology |
Procaspase-3 | Precursor form of caspase-3 | WB | Abcam |
cleaved caspase-3 | Active form of caspase-3 | WB | Abcam |
PARP | Cleavage targets of caspase-3 | WB | Abcam |
Cleaved PARP | Cleavage of PARP | WB | Abcam |
E-cadherin | Intercellular junction protein | WB | Abcam |
Vimentin | Cytoskeletal protein | WB | Abcam |
β-actin | Cytoskeletal protein | WB | Boster |
WB, Western blot; IHC, Immunohistochemistry.